O. Slot

Soluble urokinase plasminogen activator receptor in plasma of patients with inflammatory rheumatic disorders: increased concentrations in rheumatoid arthritis

Slot, O., Brunner, N., Locht, H., Oxholm, P., Stephens, R.

OBJECTIVE—Urokinase type plasminogen activator (uPA) catalyses the formation of the proteolytic enzyme plasmin, which is involved in matrix degradation in the processes of tissue remodelling....

A prospective study of vasculitis patients collected in a five year period: evaluation of the Chapel Hill nomenclature

Sorensen, S. F., Slot, O., Tvede, N., Petersen, J.

OBJECTIVE—To test the usefulness of the Chapel Hill nomenclature, supplemented with surrogate parameters, as diagnostic criteria for primary vasculitides.
METHODS—To prospectively evaluate...

Marker of erosive progression in RA

SLOT, O., BRUNNER, N., STEPHENS, R.

Release of 5-aminosalicylic acid from Pentasa during normal and accelerated intestinal transit time.

Christensen, L A, Slot, O, Sanchez, G, Boserup, J, Rasmussen, S N, Bondesen, S, ...

The influence of intestinal transit time on the release of 5-aminosalicylic acid (5-ASA) from a peroral, slow-release preparation (Pentasa) was studied at steady state in seven healthy volunteers....